Cambridge Cancer Genomics
Latest round
- Seed
Last raised
- Dec 2018
Total raised
- $4.5M
Investors
- 5
About Cambridge Cancer Genomics
Cambridge Cancer Genomics Limited is a pioneering company focused on revolutionizing cancer care through innovative genomic data solutions.Cambridge Cancer Genomics Limited, founded in 2016 in Cambridge, UK, specializes in leveraging genomic data for cancer care improvement. In June 2021, the company was acquired by Dante Genomics, enabling further integration into clinical oncology solutions.ai specializes in providing a comprehensive marketplace for domain names, focusing on expert-curated, brandable options aimed at enhancing business visibility and identity.xyz. These domains cater to various client needs, helping businesses establish a unique online presence.ai offers services such as naming contests facilitated by branding experts, AI-powered name and logo generation tools, trademark services, and data-driven survey capabilities for informed decision-making.ai generates revenue through the sale of domain names and associated branding services.com marketplace, designed for seamless transactions. The company offers a range of pricing plans, enhancing accessibility for various business sizes.ai promotes partnerships with clients through comprehensive branding solutions, which may include logo design and trademark assistance, fostering long-term relationships. The integration aims to enhance capabilities in providing clinical organizations with comprehensive oncology solutions. This acquisition facilitates reaching a broader range of clinical organizations, supporting strategies to improve patient outcomes in cancer treatment.
Who invested in Cambridge Cancer Genomics
5 investors across 1 round
See all investors in Cambridge Cancer Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 1, 2018
Amount
$4.5M
Investors
Questions about Cambridge Cancer Genomics
Who invested in Cambridge Cancer Genomics?
Cambridge Cancer Genomics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cambridge Cancer Genomics raised?
Cambridge Cancer Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cambridge Cancer Genomics last raise money?
Cambridge Cancer Genomics's most recent round on record is a Seed, in Dec 2018.
What does Cambridge Cancer Genomics do?
Cambridge Cancer Genomics Limited is a pioneering company focused on revolutionizing cancer care through innovative genomic data solutions.
Where is Cambridge Cancer Genomics headquartered?
Cambridge Cancer Genomics is headquartered in Cambridge, UK.
Which VCs invest in companies like Cambridge Cancer Genomics?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Cambridge Cancer Genomics's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Cambridge Cancer Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.